
| MICRON TECHNOLOGY, INC. | ||
| (Exact name of registrant as specified in its charter) | ||
| Delaware | 1-10658 | 75-1618004 | ||||||||||||
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||||||||
| 8000 South Federal Way | ||
Boise, Idaho 83716-9632 | ||
| (Address of principal executive offices and Zip Code) | ||
(208) 368-4000 | ||
| (Registrant’s telephone number, including area code) | ||
| Title of each class | Trading symbol | Name of each exchange on which registered | ||||||||||||
| Common Stock, par value $0.10 per share | MU | Nasdaq Global Select Market | ||||||||||||
| Item 2.02. | Results of Operations and Financial Condition. | ||||
| Item 9.01. | Financial Statements and Exhibits. | ||||
| (d) Exhibits. | |||||
| Exhibit No. | Description | |||||||
| 99.1 | ||||||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |||||||
| MICRON TECHNOLOGY, INC. | |||||||||||
| Date: | June 25, 2025 | By: | /s/ Mark Murphy | ||||||||
| Name: | Mark Murphy | ||||||||||
| Title: | Executive Vice President and Chief Financial Officer | ||||||||||
| Contacts: | Satya Kumar |
Mark Plungy |
||||||
| Investor Relations | Media Relations | |||||||
satyakumar@micron.com |
mplungy@micron.com | |||||||
(408) 450-6199 |
(408) 203-2910 |
|||||||
| Quarterly Financial Results | |||||||||||||||||||||||
| (in millions, except per share amounts) | GAAP(1) |
Non-GAAP(2) |
|||||||||||||||||||||
FQ3-25 |
FQ2-25 |
FQ3-24 |
FQ3-25 |
FQ2-25 |
FQ3-24 |
||||||||||||||||||
| Revenue | $ | 9,301 | $ | 8,053 | $ | 6,811 | $ | 9,301 | $ | 8,053 | $ | 6,811 | |||||||||||
| Gross margin | 3,508 | 2,963 | 1,832 | 3,623 | 3,053 | 1,917 | |||||||||||||||||
| percent of revenue | 37.7 | % | 36.8 | % | 26.9 | % | 39.0 | % | 37.9 | % | 28.1 | % | |||||||||||
| Operating expenses | 1,339 | 1,190 | 1,113 | 1,133 | 1,046 | 976 | |||||||||||||||||
| Operating income | 2,169 | 1,773 | 719 | 2,490 | 2,007 | 941 | |||||||||||||||||
| percent of revenue | 23.3 | % | 22.0 | % | 10.6 | % | 26.8 | % | 24.9 | % | 13.8 | % | |||||||||||
Net income |
1,885 | 1,583 | 332 | 2,181 | 1,783 | 702 | |||||||||||||||||
Diluted earnings per share |
1.68 | 1.41 | 0.30 | 1.91 | 1.56 | 0.62 | |||||||||||||||||
| FQ4-25 | GAAP(1) Outlook |
Non-GAAP(2) Outlook |
||||||
Revenue |
$10.7 billion ± $300 million | $10.7 billion ± $300 million | ||||||
Gross margin |
41.0% ± 1.0% | 42.0% ± 1.0% | ||||||
Operating expenses |
$1.35 billion ± $20 million | $1.20 billion ± $20 million | ||||||
Diluted earnings per share |
$2.29 ± $0.15 | $2.50 ± $0.15 | ||||||
3rd Qtr. |
2nd Qtr. |
3rd Qtr. |
Nine Months Ended | ||||||||||||||
| May 29, 2025 |
February 27, 2025 |
May 30, 2024 |
May 29, 2025 |
May 30, 2024 |
|||||||||||||
| Revenue | $ | 9,301 | $ | 8,053 | $ | 6,811 | $ | 26,063 | $ | 17,361 | |||||||
| Cost of goods sold | 5,793 | 5,090 | 4,979 | 16,244 | 14,485 | ||||||||||||
| Gross margin | 3,508 | 2,963 | 1,832 | 9,819 | 2,876 | ||||||||||||
| Research and development | 965 | 898 | 850 | 2,751 | 2,527 | ||||||||||||
| Selling, general, and administrative | 318 | 285 | 291 | 891 | 834 | ||||||||||||
| Other operating (income) expense, net | 56 | 7 | (28) | 61 | (267) | ||||||||||||
| Operating income (loss) | 2,169 | 1,773 | 719 | 6,116 | (218) | ||||||||||||
| Interest income | 135 | 108 | 136 | 350 | 398 | ||||||||||||
| Interest expense | (123) | (112) | (150) | (353) | (426) | ||||||||||||
| Other non-operating income (expense), net | (68) | (11) | 10 | (90) | (24) | ||||||||||||
| 2,113 | 1,758 | 715 | 6,023 | (270) | |||||||||||||
| Income tax (provision) benefit | (235) | (177) | (377) | (695) | 172 | ||||||||||||
| Equity in net income (loss) of equity method investees | 7 | 2 | (6) | 10 | (11) | ||||||||||||
| Net income (loss) | $ | 1,885 | $ | 1,583 | $ | 332 | $ | 5,338 | $ | (109) | |||||||
| Earnings (loss) per share | |||||||||||||||||
| Basic | $ | 1.69 | $ | 1.42 | $ | 0.30 | $ | 4.79 | $ | (0.10) | |||||||
| Diluted | 1.68 | 1.41 | 0.30 | 4.75 | (0.10) | ||||||||||||
| Number of shares used in per share calculations | |||||||||||||||||
| Basic | 1,118 | 1,115 | 1,107 | 1,114 | 1,104 | ||||||||||||
| Diluted | 1,125 | 1,123 | 1,123 | 1,123 | 1,104 | ||||||||||||
| As of | May 29, 2025 |
February 27, 2025 |
August 29, 2024 |
||||||||
| Assets | |||||||||||
Cash and cash equivalents |
$ | 10,163 | $ | 7,552 | $ | 7,041 | |||||
| Short-term investments | 648 | 663 | 1,065 | ||||||||
| Receivables | 7,436 | 6,504 | 6,615 | ||||||||
| Inventories | 8,727 | 9,007 | 8,875 | ||||||||
| Other current assets | 945 | 963 | 776 | ||||||||
| Total current assets | 27,919 | 24,689 | 24,372 | ||||||||
| Long-term marketable investments | 1,402 | 1,375 | 1,046 | ||||||||
| Property, plant, and equipment | 44,773 | 42,528 | 39,749 | ||||||||
| Operating lease right-of-use assets | 628 | 637 | 645 | ||||||||
| Intangible assets | 426 | 423 | 416 | ||||||||
| Deferred tax assets | 483 | 552 | 520 | ||||||||
| Goodwill | 1,150 | 1,150 | 1,150 | ||||||||
| Other noncurrent assets | 1,616 | 1,699 | 1,518 | ||||||||
| Total assets | $ | 78,397 | $ | 73,053 | $ | 69,416 | |||||
| Liabilities and equity | |||||||||||
| Accounts payable and accrued expenses | $ | 8,761 | $ | 6,176 | $ | 7,299 | |||||
| Current debt | 538 | 504 | 431 | ||||||||
| Other current liabilities | 836 | 1,197 | 1,518 | ||||||||
| Total current liabilities | 10,135 | 7,877 | 9,248 | ||||||||
| Long-term debt | 15,003 | 13,851 | 12,966 | ||||||||
| Noncurrent operating lease liabilities | 600 | 599 | 610 | ||||||||
| Noncurrent unearned government incentives | 603 | 836 | 550 | ||||||||
| Other noncurrent liabilities | 1,308 | 1,257 | 911 | ||||||||
| Total liabilities | 27,649 | 24,420 | 24,285 | ||||||||
| Commitments and contingencies | |||||||||||
| Shareholders’ equity | |||||||||||
| Common stock | 126 | 126 | 125 | ||||||||
| Additional capital | 12,960 | 12,711 | 12,115 | ||||||||
| Retained earnings | 45,559 | 43,839 | 40,877 | ||||||||
| Treasury stock | (7,852) | (7,852) | (7,852) | ||||||||
| Accumulated other comprehensive income (loss) | (45) | (191) | (134) | ||||||||
| Total equity | 50,748 | 48,633 | 45,131 | ||||||||
| Total liabilities and equity | $ | 78,397 | $ | 73,053 | $ | 69,416 | |||||
| Nine Months Ended | May 29, 2025 |
May 30, 2024 |
||||||
| Cash flows from operating activities | ||||||||
| Net income (loss) | $ | 5,338 | $ | (109) | ||||
Adjustments to reconcile net income (loss) to net cash provided by operating activities: |
||||||||
| Depreciation expense and amortization of intangible assets | 6,203 | 5,794 | ||||||
Stock-based compensation |
722 | 620 | ||||||
Change in operating assets and liabilities: |
||||||||
| Receivables | (123) | (2,562) | ||||||
| Inventories | 148 | (125) | ||||||
Other current assets |
(206) | (435) | ||||||
| Accounts payable and accrued expenses | 38 | 846 | ||||||
Other current liabilities |
(681) | 769 | ||||||
| Other | 356 | 304 | ||||||
| Net cash provided by operating activities | 11,795 | 5,102 | ||||||
| Cash flows from investing activities | ||||||||
| Expenditures for property, plant, and equipment | (10,199) | (5,266) | ||||||
| Purchases of available-for-sale securities | (1,203) | (1,110) | ||||||
| Proceeds from government incentives | 1,294 | 267 | ||||||
Proceeds from maturities and sales of available-for-sale securities |
1,249 | 1,433 | ||||||
| Other | (30) | (35) | ||||||
Net cash used for investing activities |
(8,889) | (4,711) | ||||||
| Cash flows from financing activities | ||||||||
Proceeds from issuance of debt |
4,430 | 999 | ||||||
| Repayments of debt | (3,604) | (1,816) | ||||||
| Payments of dividends to shareholders | (392) | (384) | ||||||
| Payments on equipment purchase contracts | — | (127) | ||||||
| Other | (220) | (40) | ||||||
Net cash provided by (used for) financing activities |
214 | (1,368) | ||||||
Effect of changes in currency exchange rates on cash, cash equivalents, and restricted cash |
(3) | (15) | ||||||
| Net increase (decrease) in cash, cash equivalents, and restricted cash | 3,117 | (992) | ||||||
| Cash, cash equivalents, and restricted cash at beginning of period | 7,052 | 8,656 | ||||||
| Cash, cash equivalents, and restricted cash at end of period | $ | 10,169 | $ | 7,664 | ||||
| 3rd Qtr. | 2nd Qtr. | 3rd Qtr. | |||||||||
| May 29, 2025 |
February 27, 2025 |
May 30, 2024 |
|||||||||
| GAAP gross margin | $ | 3,508 | $ | 2,963 | $ | 1,832 | |||||
| Stock-based compensation | 115 | 89 | 80 | ||||||||
| Other | — | 1 | 5 | ||||||||
| Non-GAAP gross margin | $ | 3,623 | $ | 3,053 | $ | 1,917 | |||||
| GAAP operating expenses | $ | 1,339 | $ | 1,190 | $ | 1,113 | |||||
| Stock-based compensation | (148) | (144) | (137) | ||||||||
Patent license charges |
(57) | — | — | ||||||||
Other |
(1) | — | — | ||||||||
| Non-GAAP operating expenses | $ | 1,133 | $ | 1,046 | $ | 976 | |||||
GAAP operating income |
$ | 2,169 | $ | 1,773 | $ | 719 | |||||
| Stock-based compensation | 263 | 233 | 217 | ||||||||
Patent license charges |
57 | — | — | ||||||||
| Other | 1 | 1 | 5 | ||||||||
Non-GAAP operating income |
$ | 2,490 | $ | 2,007 | $ | 941 | |||||
GAAP net income |
$ | 1,885 | $ | 1,583 | $ | 332 | |||||
| Stock-based compensation | 263 | 233 | 217 | ||||||||
Patent license charges |
57 | — | — | ||||||||
Loss on debt prepayments |
46 | 4 | — | ||||||||
| Other | 1 | — | 3 | ||||||||
Estimated tax effects of above and other tax adjustments |
(71) | (37) | 150 | ||||||||
Non-GAAP net income |
$ | 2,181 | $ | 1,783 | $ | 702 | |||||
GAAP weighted-average common shares outstanding - Diluted |
1,125 | 1,123 | 1,123 | ||||||||
Adjustment for stock-based compensation |
19 | 20 | 13 | ||||||||
Non-GAAP weighted-average common shares outstanding - Diluted |
1,144 | 1,143 | 1,136 | ||||||||
GAAP diluted earnings per share |
$ | 1.68 | $ | 1.41 | $ | 0.30 | |||||
Effects of the above adjustments |
0.23 | 0.15 | 0.32 | ||||||||
Non-GAAP diluted earnings per share |
$ | 1.91 | $ | 1.56 | $ | 0.62 | |||||
| 3rd Qtr. | 2nd Qtr. | 3rd Qtr. | |||||||||
| May 29, 2025 |
February 27, 2025 |
May 30, 2024 |
|||||||||
GAAP net cash provided by operating activities |
$ | 4,609 | $ | 3,942 | $ | 2,482 | |||||
Expenditures for property, plant, and equipment |
(2,938) | (4,055) | (2,086) | ||||||||
| Payments on equipment purchase contracts | — | — | (45) | ||||||||
| Proceeds from sales of property, plant, and equipment | 12 | 7 | 41 | ||||||||
Proceeds from government incentives |
266 | 963 | 33 | ||||||||
| Investments in capital expenditures, net | (2,660) | (3,085) | (2,057) | ||||||||
Adjusted free cash flow |
$ | 1,949 | $ | 857 | $ | 425 | |||||
FQ4-25 |
GAAP Outlook | Adjustments | Non-GAAP Outlook | ||||||||||||||||||||
Revenue |
$10.7 billion ± $300 million |
— | $10.7 billion ± $300 million |
||||||||||||||||||||
Gross margin |
41.0% ± 1.0% |
1.0% |
A | 42.0% ± 1.0% |
|||||||||||||||||||
Operating expenses |
$1.35 billion ± $20 million |
$147 million |
B | $1.20 billion ± $20 million |
|||||||||||||||||||
Diluted earnings per share(1) |
$2.29 ± $0.15 |
$0.21 |
A, B, C | $2.50 ± $0.15 |
|||||||||||||||||||
|
Non-GAAP Adjustments
(in millions)
|
|||||||||||||||||||||||
A |
Stock-based compensation – cost of goods sold |
$ | 119 | ||||||||||||||||||||
B |
Stock-based compensation – research and development |
93 | |||||||||||||||||||||
B |
Stock-based compensation – sales, general, and administrative |
54 | |||||||||||||||||||||
C |
Tax effects of the above items and other tax adjustments | (27) | |||||||||||||||||||||
| $ | 239 | ||||||||||||||||||||||